
The First $100 Billion Drug
Barron's Streetwise
00:00
The Progress in Oncology and Immunotherapy
Despite the likely approval of SI and biogen's drug, it's called lakana map. There's still a lot in the oncology and hematology space. Obesity, I think, is going to be really the for a few years commercially. The Wall Street Journal's Your Money Briefing podcast breaks down complex financial issues.
Transcript
Play full episode